The global peptide therapeutics market was valued at nearly $50 billion in 2024, and its projected to reach up to around $84 billion by 2034.1 One of the most well-known peptides in recent years is semaglutide (Ozempic), a glucagon-like peptide-1 receptor agonist (GLP-1) used for the treatment of type 2 diabetes.2 However, semaglutide is just one of many different peptides that could potentially lead to health benefits
[DOI] [PubMed] [Google Scholar] 92.Rouette J., Yin H., Yu O.H.Y., Bouganim N., Platt R.W., Azoulay L
doi:10.1002/open.201200014 32
These reactive intermediates may react with proteins, lipids and nucleotides, and it has been reported to form tyrosine halogenation such as dibromotyrosine (DiBrY)
Third-Party Testing Standards in 2026 Third-party analytical testing is now expected for credible suppliers in 2026
So that's kind of where we're considering all these variables